These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17360963)

  • 21. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Centorrino T; Siriwardena AK; Cuzzocrea S
    Shock; 2007 May; 27(5):542-51. PubMed ID: 17438460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese.
    Horiuchi T; Tsukamoto H; Mitoma H; Miyagawa H; Tamimoto Y; Yoshizawa S; Harada M; Hayashi K; Hashimura C; Oribe M; Okamura S
    Int J Mol Med; 2004 Nov; 14(5):813-8. PubMed ID: 15492850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First report of rapidly progressive glomerulonephritis in tumor necrosis factor receptor-associated periodic syndrome.
    Harambat J; Desjonqueres M; Garaix F; Cochat P; Ranchin B; Cimaz R; Dodé C; Bouvier R
    Arthritis Rheum; 2008 Oct; 58(10):3275-6. PubMed ID: 18821681
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe cutaneous reaction and fever due to adalimumab.
    Gonzalo-Garijo MA; Rodríguez-Nevado I; Pérez-Calderón R; Sánchez-Vega S; Pérez-Rangel I
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):490-1. PubMed ID: 21130390
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.
    Drewe E; Huggins ML; Morgan AG; Cassidy MJ; Powell RJ
    Rheumatology (Oxford); 2004 Nov; 43(11):1405-8. PubMed ID: 15316120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
    Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
    Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulsating back pain associated with tumor necrosis factor-alpha blockade.
    Rozin AP; Braun-Moscovici Y; Balbir-Gurman A
    Ann Pharmacother; 2008 Dec; 42(12):1912-3. PubMed ID: 19033477
    [No Abstract]   [Full Text] [Related]  

  • 28. Heterogeneity of tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Siebert et al.
    Todd I; Nowlan ML; Drewe E; Tighe PJ; Powell RJ
    Arthritis Rheum; 2005 Sep; 52(9):2952; author reply 2952-3. PubMed ID: 16142725
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.
    Drewe E; McDermott EM; Powell RJ
    N Engl J Med; 2000 Oct; 343(14):1044-5. PubMed ID: 11023397
    [No Abstract]   [Full Text] [Related]  

  • 30. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
    Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
    Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family.
    Dinc A; Erdem H; Rowczenio D; Simsek I; Pay S; Bahce M; Lachmann H
    J Nephrol; 2005; 18(5):626-9. PubMed ID: 16299693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.
    Martinez LC; Harrison-Balestra C; Caeiro JP; Nousari CH
    Arch Dermatol; 2007 Jun; 143(6):809-10. PubMed ID: 17576961
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).
    Siebert S; Amos N; Lawson TM
    Rheumatology (Oxford); 2008 Feb; 47(2):228-9. PubMed ID: 18056150
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of pemphigus vulgaris with etanercept in four patients.
    Shetty A; Marcum CB; Glass LF; Carter JD
    J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perispinal etanercept for neuroinflammatory disorders.
    Tobinick E
    Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ILVEN: is it psoriasis? Debate based on successful treatment with etanercept.
    Renner R; Colsman A; Sticherling M
    Acta Derm Venereol; 2008; 88(6):631-2. PubMed ID: 19002357
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: comment on the articles by Hull et al and Dodé et al.
    Drewe E; Lanyon PC; Powell RJ
    Arthritis Rheum; 2003 Jun; 48(6):1768-9; author reply 1769-70. PubMed ID: 12794852
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful treatment of delayed pressure urticaria with anti-TNF-alpha.
    Magerl M; Philipp S; Manasterski M; Friedrich M; Maurer M
    J Allergy Clin Immunol; 2007 Mar; 119(3):752-4. PubMed ID: 17336621
    [No Abstract]   [Full Text] [Related]  

  • 40. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.